{"name":"Sinovac Biotech (Hong Kong) Limited","slug":"sinovac-biotech-hong-kong-limited","ticker":"","exchange":"","domain":"","description":"Sinovac Biotech Ltd. is a Chinese biopharmaceutical company based in Haidian District, Beijing that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company was listed on the Nasdaq but the exchange halted Sinovac's trading in February 2019 due to a proxy fight. The company has faced bribery probes in China. Its COVID-19 vaccine was the target of a covert disinformation campaign by the US government and a promotional social media astroturfing campaign by the Chinese government.","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPQ0IyRmpWZzhoSnhlMVFEdVdtRzM2TjRtN0FfSXp5YjBSMHJVcGZwNlJxR09OODhWQWhIM3NRcV9pdEczQUhiaEs1aXpXYVlRWFlWb1k5QVVfd0t5bmQxRmVGblpDZVM4SmRtN2taaExmRU9KN3BmLU95bVRRM1V4aWtYaEZQVGpZNzRsOEVrSTdVc2FiVTFDcDJhb19DczA5M2IzM0FR?oc=5","date":"2025-12-09","type":"pipeline","source":"BioWorld News","summary":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025 - BioWorld News","headline":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBCc2ZNajA5ZTdKWHJBUnJlbVJlSnNYeGo1WDE4Q3F0VHM1RVFZbnUtWGJ3N2RhcDB1Tm8ySVg5ZFFyUHJyRGMzVVV5cVlzeHJ5azFr?oc=5","date":"2025-11-27","type":"pipeline","source":"36 Kr","summary":"8:00 AM, 1st Kr: 44 Dead in Hong Kong Fire, Luo Yonghao Calls for Hua Shan's Public Apology with No Response, 10 Airlines Summoned over Disguised Plane Seat - Locking Charges - 36 Kr","headline":"8:00 AM, 1st Kr: 44 Dead in Hong Kong Fire, Luo Yonghao Calls for Hua Shan's Public Apology with No Response, 10 Airline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUVFKUlM3VklxX0hfQlU1MUhjWEw1enBPZmdCNXRlUGstakhlVzB2V05uNlpzVG9XNzJreU9UWEtkSlhfelhhei15UmJObk9UaTEyLTVDZEw3RjhpM3czbE1TNUtfR0MyeThNSGRHVmpjNFF0a0lnOUdRNEpCZWRQYWJhZ1I2dW1jNjFxcGhVdEtnM3Z3VmNUTjFvdzFxWWNiOXhzUXRDQWxvUQ?oc=5","date":"2025-06-27","type":"pipeline","source":"Reuters","summary":"Breakingviews - Biotech nears cure for Chinese corporate epidemic - Reuters","headline":"Breakingviews - Biotech nears cure for Chinese corporate epidemic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPSHR0YWV0ZFI2R3ZYOS1JM01jMjAzV29mYWZFazhMSko2UjRLWXdWNUdsZ05ORElhVkFMUEdWNWgzYkFvVnlFV0tCSklWYjdYeElUN20tcE9fTVlTdTlsNENVTktNTVpKT2FMcmR3YnRVWjVTc2xSYWJ1WEhNSGhlMC13?oc=5","date":"2025-03-08","type":"pipeline","source":"fDi Intelligence","summary":"Sinovac expands in LatAm despite China fiasco - fDi Intelligence","headline":"Sinovac expands in LatAm despite China fiasco","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBoV2tLeFZ3alN0VVpuX3luS3VmNGpSSmZNb3ZZQ3pVYzJQRmM1OWo0emVHVVlXbHotUjAxeHM1U21aQ19uNFVVdmZkek1DMldJYUc5Zk1BT1NDbDhrbFNR?oc=5","date":"2023-03-21","type":"regulatory","source":"Time Magazine","summary":"China Approves Its First mRNA COVID Vaccine - Time Magazine","headline":"China Approves Its First mRNA COVID Vaccine","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOam5KcG95amVfNElxY0ZrV2RqQVZQYnhxM1FmOU9BY3VRN3ZRTXVtVkxlSVE2Q0NoMzF5UEEtX092Z1ZEY1JVU0gwQndaWEN3dkQ5NnJNcGNWRURzSll5YUEtcVpWRWZnaThYTDV3bzh2dldjY0NnLVV5ZFAxeVZlSF9qR0dLcXFscnRlQ3RHQ2tLM1FjcGN6eHBpMHZ0ZXBx?oc=5","date":"2022-10-03","type":"pipeline","source":"BioSpectrum Asia","summary":"Why Life Sciences sector is Soaring in China - BioSpectrum Asia","headline":"Why Life Sciences sector is Soaring in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE9yM2JGMVVxdkg5ZWRQSEF3SUFKSXc1TzBLcjhfN0Z2cFA4OVgtcWdMQ0VCTV9FQXB6STRoS0JoLTVXTXRfSUlPMVdCZ09mOVNyS19LWEoxQjBMUTJaN1QzQjNhREdsZ0ZtNjhDd1JSejRIRmNveEE?oc=5","date":"2021-05-28","type":"pipeline","source":"The Chinese University of Hong Kong","summary":"Which vaccine should I take? - The Chinese University of Hong Kong","headline":"Which vaccine should I take?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-02-18","type":"pipeline","source":"South China Morning Post","summary":"The Covid-19 vaccines for Hong Kong, and what suits you - South China Morning Post","headline":"The Covid-19 vaccines for Hong Kong, and what suits you","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxQcURRWThlTXYxcEgyYUJlRHUwSWRlRXk3UjJUdS05NnkwU1dYUGkzWmlYRHRwd3NFUmJ1cFE2bkpzeFdEZ0hWbWY1N24zS011aVpBR0M1REJxNHhOQjQ0VG1heGlNbkVJQU5mYXpIYTFrR1dfUXI5Z0hJdUZwd3JqaGlzTmpKSGZjbnM1RjNTNTdsUVNHXzRoTWk2bl9CaTRTWjdKNVFtTERKZ2JVMzRGWExwbnlZd0V6SzRhd2Z6a1lMaXRhQUlMNDQ5T2pwUmppTmJVbkh5SFFTYnNMeUgxVkN3aWxTNkN0bVlSMEVTMA?oc=5","date":"2020-12-24","type":"trial","source":"The Boston Globe","summary":"Chinese pharmaceutical firm Sinovac says its COVID-19 vaccine is more than 50 percent effective, but data withheld - The Boston Globe","headline":"Chinese pharmaceutical firm Sinovac says its COVID-19 vaccine is more than 50 percent effective, but data withheld","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5oMlFtYll6V1JPcXd5bkhSd05OQkdudkpzS0hQcTkwYV9SY2tkU2F6SG5xTmg1NDhROVV4NUw5VnBnR0VCcFBDNXpoVmlobFktY2U4UnMzeHd3Y2JHTWtJaU52VF9DS3NUTllRYkhCWkRqVmZ5ZWpiczZNWQ?oc=5","date":"2020-12-07","type":"pipeline","source":"Latham & Watkins LLP","summary":"Latham Advises Sinovac in Securing Approximately US$500 Million in Funding for COVID-19 Vaccine Development - Latham & Watkins LLP","headline":"Latham Advises Sinovac in Securing Approximately US$500 Million in Funding for COVID-19 Vaccine Development - Latham & W","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPMnZsc2R1UHFrZjBad2R0YXdJeUFjUG1XRk5kY0dHQlNnUERFUDdBYk16ZkNXbWhGQThxaU1GanZHY3VkaV9PWkN6cUdRVHJDVnlpNWtqY2x1VFN3MzR4SzF2czhxQjhQLTJOZHozeUtxYUlxdWZwRVh2YXdvSDVWODhBUE5jNDFNS0xGOHJLYy0wSW9fcXZxZEl0bkZPSHE4NDU3OTBHdHpocmlLSW1ycUVzckhMMkdlaXNLLXlHaEo2V3c?oc=5","date":"2019-03-01","type":"patent","source":"Fierce Pharma","summary":"FiercePharmaAsia—Daiichi Sankyo shakeup; China’s first biosimilar; Sinovac ‘poison pill’ defense - Fierce Pharma","headline":"FiercePharmaAsia—Daiichi Sankyo shakeup; China’s first biosimilar; Sinovac ‘poison pill’ defense","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE5NWUxzRjBRZ3hqWnJwV1BpT1g4UmtzSTFZZy1CYzFNVVN2STNQeEpzNWtyTXpYUU5ZeG1PSWVmdWtxOFlsQlE4T0dfZkc5bm9pZVdudw?oc=5","date":"2018-01-26","type":"pipeline","source":"nature.com","summary":"Chinese health biotech and the billion-patient market - nature.com","headline":"Chinese health biotech and the billion-patient market","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}